Kalium Lakes EBITDA margin
What is the EBITDA margin of Kalium Lakes?
The EBITDA margin of Kalium Lakes Limited is -412.10%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Materials sector on ASX compared to Kalium Lakes
What does Kalium Lakes do?
Kalium Lakes Limited operates as an exploration and development company in Australia. It focuses on the development of 100% owned the Beyondie sulphate of potash project, which include 16 granted exploration licenses, two mining leases, and various miscellaneous licenses covering an area of approximately 1,800 square kilometers located in Western Australia. The company was founded in 2014 and is based in Balcatta, Australia.
Companies with ebitda margin similar to Kalium Lakes
- Vir Biotechnology Inc has EBITDA margin of -415.62%
- Ondas has EBITDA margin of -414.74%
- Axios Mobile Assets has EBITDA margin of -414.57%
- Nuheara has EBITDA margin of -413.72%
- Alterity Therapeutics has EBITDA margin of -412.91%
- Alterity Therapeutics has EBITDA margin of -412.91%
- Kalium Lakes has EBITDA margin of -412.10%
- Co-Diagnostics Inc has EBITDA margin of -411.73%
- Atara Biotherapeutics has EBITDA margin of -411.00%
- Opgen Inc has EBITDA margin of -410.85%
- Titan Medical has EBITDA margin of -408.50%
- Stroud Resources has EBITDA margin of -406.72%
- Last Mile has EBITDA margin of -406.59%